Experimental therapeutics in transgenic mouse models of Huntington's disease

This publication has 136 references indexed in Scilit:

• A Rapid Cellular FRET Assay of Polyglutamine Aggregation Identifies a Novel Inhibitor
  Neuron, 2003
• Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia
  Annals of Neurology, 2003
• Huntington's Disease of the Endocrine Pancreas: Insulin Deficiency and Diabetes Mellitus due to Impaired Insulin Gene Expression
  Neurobiology of Disease, 2002
• Proteases Acting on Mutant Huntingtin Generate Cleaved Products that Differentially Build Up Cytoplasmic and Nuclear Inclusions
  Published by Elsevier ,2002
• Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease
  Movement Disorders, 2002
• Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
  Nature Neuroscience, 2002
• Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease
  Annals of Neurology, 2001
• Striatal Transplantation in a Transgenic Mouse Model of Huntington's Disease
  Experimental Neurology, 1998
• Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice
  Cell, 1996
• Long-Term Treatment of Girls with Ornithine Transcarbamylase Deficiency
  New England Journal of Medicine, 1996